Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sarpogrelate and high-dose statin for reduction of coronary spasm in variant angina
KCT0000623Phase 4Recruiting
- Sponsor
- Yuhan
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sarpogrelate in Coronary vasospasm (CAS), sponsored by Yuhan. Started Nov 2012; status: recruiting.
02
Drugs
sarpogrelate
03
Conditions
Coronary vasospasm (CAS)
Beyond the preview
Go deeper on KCT0000623.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000623.